RxDoctor Payments Data

Daniel Rosner, MD

Plastic Surgery within the Head & Neck · Myrtle Beach, SCNPI 1124087101

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations.

$3,380in general payments, 2019–2025

Across 105 payments — averaging $32.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$688
  • Optinose US, Inc.$357
  • GSK$338
  • Acera Surgical, Inc.$313
  • Medtronic$272
  • Regeneron Healthcare Solutions, Inc.$259
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,380100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic surgery within the head & neck providers in South Carolinato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$493,093
Medicare patients
1,665
Services billed
6,122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl643$16,404
Ipratropium Bromide290$8,062
Fluticasone Propionate319$3,961
Famotidine396$2,899
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort48$2,451
CefuroximeCefuroxime Axetil161$2,191
Ofloxacin138$1,537
Triamcinolone Acetonide12$1,461
Prednisolone Acetate44$1,192
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip104$930
Doxycycline Hyclate67$712
Prednisone233$573
Clotrimazole27$567
Montelukast Sodium35$383
Sulfacetamide Sodium12$378

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head & neck in Myrtle Beach

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →